United States (U.S.) Department of Health and HumanServices. Viral Hepatitis National Strategic Plan for the United States: A Roadmap to Elimination (2021–2025). WashingtonDC.2020. https://www.hhs.gov/sites/default/files/Viral-Hepatitis-National-Strategic-Plan-2021-2025.pdf Accessed February10, 2021.
2.
SchillieS, WesterC, OsborneM, WesolowskiL, RyersonAB. CDC Recommendations for hepatitis C screening among adults—United States, 2020. MMWR Recomm Rep, 2020; 69:1–17.
3.
NguyenMH, Burak OzbayA, LiouL, et al.Healthcare resource utilization and costs by disease severity in an insured national sample of U.S. patients with chronic hepatitis B. J Hepatol, 2019; 70:24–32.
4.
WongRJ, JainMK, TherapondosG, et al.Race/ethnicity and insurance status disparities in access to direct acting antivirals for hepatitis C virus treatment. Am J Gastroenterol, 2018; 113:1329–1338.
5.
National Viral Hepatitis Roundtable; Center for Health Law and PolicyInnovation, Harvard LawSchool. HepatitisC: State of MedicaidAccess. https://stateofhepc.org/ Accessed February11, 2021.
6.
SpradlingPR, XingJ, RuppLB, et al.Infrequent clinical assessment of chronic hepatitis B patients in United States general healthcare settings. Clin Infect Dis, 2016; 63:1205–1208.
7.
Massachusetts Medical Society. Assessment of the Impact of High-Deductible Health Plans on Patient Health and the Financial Impact on Medical Practices. 2017. www.massmed.org/News-and-Publications/Research-and-Studies/High-Deductible-White-Paper-2017/ Accessed February10, 2021.
8.
HofmeisterMG, RosenthalEM, BarkerLK, et al.Estimating prevalence of hepatitis C virus infection in the United States, 2013–2016. Hepatology, 2019; 69:1020–1031.
9.
PatelEU, ThioCL, BoonD, et al.Prevalence of hepatitis B and hepatitis D virus infections in the United States, 2011–2016. Clin Infect Dis, 2019; 69:709–712.
10.
EdlinBR, EckhardtBJ, ShuMA, HolmbergSD, SwanT. Toward a more accurate estimate of the prevalence of hepatitis C in the United States. Hepatology, 2015; 62:1353–1363.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
